Dherya Bahl
About
In The Last Decade
Dherya Bahl
15 papers receiving 352 citations
Peers
Comparison fields: 5 of 75
- Materials Chemistry 110
- Biomaterials 89
- Pharmaceutical Science 68
- Molecular Medicine 66
- Molecular Biology 63
Countries citing papers authored by Dherya Bahl
This map shows the geographic impact of Dherya Bahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dherya Bahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dherya Bahl more than expected).
Fields of papers citing papers by Dherya Bahl
This network shows the impact of papers produced by Dherya Bahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dherya Bahl. The network helps show where Dherya Bahl may publish in the future.
Co-authorship network of co-authors of Dherya Bahl
This figure shows the co-authorship network connecting the top 25 collaborators of Dherya Bahl. A scholar is included among the top collaborators of Dherya Bahl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dherya Bahl. Dherya Bahl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 30 | |
| 5 | 8 | |
| 6 | 12 | |
| 7 | 17 | |
| 8 | 35 | |
| 9 | 11 | |
| 10 | 6 | |
| 11 | 125 | |
| 12 | 13 | |
| 13 | 37 | |
| 14 | An overview on antitubercular activities of fluoroquinolones and other related analogues | 3 |
| 15 | A Comprehensive Drug Review on Macitentan: A Preeminent Inclusion to Pulmonary Arterial Hypertension Therapy | 1 |
| 16 | 60 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.